USA - NASDAQ:OMDA - US68170A1088 - Common Stock
The current stock price of OMDA is 22.445 USD. In the past month the price decreased by -5.78%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CVS | CVS HEALTH CORP | 11.78 | 94.72B | ||
CI | THE CIGNA GROUP | 10.32 | 77.36B | ||
LH | LABCORP HOLDINGS INC | 18.79 | 23.64B | ||
DGX | QUEST DIAGNOSTICS INC | 20.13 | 21.29B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 130.51 | 17.11B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 12.8 | 15.32B | ||
HIMS | HIMS & HERS HEALTH INC | 71.18 | 12.87B | ||
DVA | DAVITA INC | 13.64 | 9.45B | ||
GH | GUARDANT HEALTH INC | N/A | 7.75B | ||
CHE | CHEMED CORP | 19.99 | 6.52B | ||
RDNT | RADNET INC | 212.17 | 5.88B | ||
BTSG | BRIGHTSPRING HEALTH SERVICES | 39.28 | 5.15B |
Omada Health, Inc. engages in the provision of digital health services. The company is headquartered in San Francisco, California and currently employs 859 full-time employees. The company went IPO on 2025-06-06. The firm has one operating segment, namely all virtual care program product offerings. The Company’s member-facing platform is designed to offer an integrated experience that encompasses the full range of direct interactions. The company offers range of programs like Omada for Prevention & Weight Health, Omada for Diabetes, Omada for Hypertension, Omada for musculoskeletal (MSK), and Omada GLP-1 Care Tracks. Its Omada for Prevention & Weight Health programs focus on prediabetes and weight management, two critical elements of preventing diabetes and heart disease. Its Omada for Diabetes program is designed to help members with type 1 or type 2 diabetes achieve stable blood glucose levels and meet and reach their goals for reducing hemoglobin A1C. Its Omada for Hypertension is designed to help reduce members blood pressure and help them maintain healthy blood pressure.
OMADA HEALTH INC
500 Sansome Street, Suite 200
San Francisco CALIFORNIA US
Employees: 859
Phone: 18889878337
The current stock price of OMDA is 22.445 USD. The price increased by 0.56% in the last trading session.
The exchange symbol of OMADA HEALTH INC is OMDA and it is listed on the Nasdaq exchange.
OMDA stock is listed on the Nasdaq exchange.
14 analysts have analysed OMDA and the average price target is 27.8 USD. This implies a price increase of 23.84% is expected in the next year compared to the current price of 22.445. Check the OMADA HEALTH INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
OMADA HEALTH INC (OMDA) has a market capitalization of 1.29B USD. This makes OMDA a Small Cap stock.
OMADA HEALTH INC (OMDA) currently has 859 employees.
OMADA HEALTH INC (OMDA) has a support level at 21.58 and a resistance level at 22.91. Check the full technical report for a detailed analysis of OMDA support and resistance levels.
The Revenue of OMADA HEALTH INC (OMDA) is expected to grow by 43.42% in the next year. Check the estimates tab for more information on the OMDA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
OMDA does not pay a dividend.
OMADA HEALTH INC (OMDA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.85).
The outstanding short interest for OMADA HEALTH INC (OMDA) is 3.29% of its float. Check the ownership tab for more information on the OMDA short interest.
ChartMill assigns a technical rating of 4 / 10 to OMDA.
ChartMill assigns a fundamental rating of 3 / 10 to OMDA. The financial health of OMDA is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months OMDA reported a non-GAAP Earnings per Share(EPS) of -0.85. The EPS increased by 30.18% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -15.56% | ||
ROE | -22% | ||
Debt/Equity | 0.14 |
14 analysts have analysed OMDA and the average price target is 27.8 USD. This implies a price increase of 23.84% is expected in the next year compared to the current price of 22.445.
For the next year, analysts expect an EPS growth of 55.94% and a revenue growth 43.42% for OMDA